SIRT1 and idiopathic pulmonary fibrosis: Moreover, Sirt1-siRNA or compound C treatment reversed the inhibition of cellular senescence in miR-199a-5p inhibitor-treated IPF-MSCs as demonstrated by SA-β-gal staining (Fig. 5g).